(Q38078780)

28 August 2017

0 references

1 reference

title

GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis (English)

1 reference

28 August 2017

0 references

1 reference

1 reference

C Li

1

1 reference

28 August 2017

J Long

series ordinal

2

1 reference

28 August 2017

X Hu

series ordinal

3

1 reference

28 August 2017

Y Zhou

series ordinal

4

1 reference

28 August 2017

language of work or name

1 reference

2 February 2013

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

28 August 2017

published in

1 reference

28 August 2017

volume

32

1 reference

28 August 2017

issue

7

1 reference

28 August 2017

page(s)

859-868

1 reference

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Isoniazid-associated hepatitis. Report of an outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

An official ATS statement: hepatotoxicity of antituberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Antituberculosis drug-induced hepatotoxicity: concise up-to-date review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Quantitative synthesis in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Genetic polymorphisms of cytochrome P450 and glutathione S-transferase associated with antituberculosis drug-induced hepatotoxicity in Chinese tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

A study to survey susceptible genetic factors responsible for troglitazone‐associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Uncertainty in heterogeneity estimates in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1831-Y

Theta, a new class of glutathione transferases purified from rat and man

21 January 2018

1 reference

12 December 2020

Study of the frequencies of CYP1A1 gene polymorphisms and glutathione S-transferase mu1 gene in primary breast cancers: an update with an additional 114 cases

1 reference

12 December 2020

Role of glutathione in protecting endothelial cells against hydrogen peroxide oxidant injury

1 reference

12 December 2020

Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury

1 reference

12 December 2020

Selective modification of glutathione metabolism

1 reference

12 December 2020

Variations in the glutathione S-transferase subunits expressed in human livers

1 reference

12 December 2020

Reactive metabolites and their role in drug reactions

1 reference

12 December 2020

[The effect of GST M1 and GST T1 gene mutations on anti-tuberculous drug induced hepatic injury].

1 reference

12 December 2020

WHO global tuberculosis control report 2010. Summary

1 reference

12 December 2020

Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity

1 reference

12 December 2020

Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patients

1 reference

12 December 2020

Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis

1 reference

12 December 2020

Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis

1 reference

12 December 2020

Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione

1 reference

12 December 2020

Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society

1 reference

12 December 2020

10.1007/S10096-013-1831-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1022247614

0 references

1 reference